These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma. Zhang AY; Lai CL; Poon RT; Huang FY; Seto WK; Fung J; Wong DK; Yuen MF J Gastroenterol Hepatol; 2016 Sep; 31(9):1638-45. PubMed ID: 26905957 [TBL] [Abstract][Full Text] [Related]
24. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal. Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044 [TBL] [Abstract][Full Text] [Related]
25. Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma. Lin DC; Mayakonda A; Dinh HQ; Huang P; Lin L; Liu X; Ding LW; Wang J; Berman BP; Song EW; Yin D; Koeffler HP Cancer Res; 2017 May; 77(9):2255-2265. PubMed ID: 28302680 [TBL] [Abstract][Full Text] [Related]
26. Identifying the clonal origin of synchronous multifocal tumors in the hepatobiliary and pancreatic system using multi-omic platforms. Jiang W; Ding Y; Shen Y; Fan L; Zhou L; Li Z; Zheng Y; Zhao P; Liu L; Tong Z; Fang W; Wang W Oncotarget; 2017 Jan; 8(3):5016-5025. PubMed ID: 28008139 [TBL] [Abstract][Full Text] [Related]
27. Determination of genomic copy number alteration emphasizing a restriction site-based strategy of genome re-sequencing. Zheng C; Miao X; Li Y; Huang Y; Ruan J; Ma X; Wang L; Wu CI; Cai J Bioinformatics; 2013 Nov; 29(22):2813-21. PubMed ID: 23962614 [TBL] [Abstract][Full Text] [Related]
28. TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma. Ki Kim S; Ueda Y; Hatano E; Kakiuchi N; Takeda H; Goto T; Shimizu T; Yoshida K; Ikura Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Uemoto S; Chiba T; Ogawa S; Marusawa H Int J Cancer; 2016 Dec; 139(11):2512-8. PubMed ID: 27511114 [TBL] [Abstract][Full Text] [Related]
29. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma. Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368 [TBL] [Abstract][Full Text] [Related]
30. Profiling of exome mutations associated with progression of HBV-related hepatocellular carcinoma. Woo HG; Kim SS; Cho H; Kwon SM; Cho HJ; Ahn SJ; Park ES; Lee JS; Cho SW; Cheong JY PLoS One; 2014; 9(12):e115152. PubMed ID: 25521761 [TBL] [Abstract][Full Text] [Related]
31. Genomic landscape of hepatocellular carcinoma in Egyptian patients by whole exome sequencing. Kassem PH; Montasser IF; Mahmoud RM; Ghorab RA; AbdelHakam DA; Fathi MESA; Wahed MAA; Mohey K; Ibrahim M; Hadidi ME; Masssoud YM; Salah M; Abugable A; Bahaa M; Khamisy SE; Meteini ME BMC Med Genomics; 2024 Aug; 17(1):202. PubMed ID: 39123171 [TBL] [Abstract][Full Text] [Related]
32. Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma. Xu LX; He MH; Dai ZH; Yu J; Wang JG; Li XC; Jiang BB; Ke ZF; Su TH; Peng ZW; Guo Y; Chen ZB; Chen SL; Peng S; Kuang M Ann Oncol; 2019 Jun; 30(6):990-997. PubMed ID: 30916311 [TBL] [Abstract][Full Text] [Related]
33. A system for detecting high impact-low frequency mutations in primary tumors and metastases. Anjanappa M; Hao Y; Simpson ER; Bhat-Nakshatri P; Nelson JB; Tersey SA; Mirmira RG; Cohen-Gadol AA; Saadatzadeh MR; Li L; Fang F; Nephew KP; Miller KD; Liu Y; Nakshatri H Oncogene; 2018 Jan; 37(2):185-196. PubMed ID: 28892047 [TBL] [Abstract][Full Text] [Related]
34. Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma. Huang A; Zhao X; Yang XR; Li FQ; Zhou XL; Wu K; Zhang X; Sun QM; Cao Y; Zhu HM; Wang XD; Yang HM; Wang J; Tang ZY; Hou Y; Fan J; Zhou J J Hepatol; 2017 Aug; 67(2):293-301. PubMed ID: 28323123 [TBL] [Abstract][Full Text] [Related]
35. Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma. Jang JW; Chun JY; Park YM; Shin SK; Yoo W; Kim SO; Hong SP Cancer Sci; 2012 Feb; 103(2):296-304. PubMed ID: 22136288 [TBL] [Abstract][Full Text] [Related]
36. Hepatocellular carcinoma in patients from northern Sweden with acute intermittent porphyria: morphology and mutations. Bjersing L; Andersson C; Lithner F Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):393-7. PubMed ID: 9162306 [TBL] [Abstract][Full Text] [Related]
37. The genomic landscape of hepatoblastoma and their progenies with HCC-like features. Eichenmüller M; Trippel F; Kreuder M; Beck A; Schwarzmayr T; Häberle B; Cairo S; Leuschner I; von Schweinitz D; Strom TM; Kappler R J Hepatol; 2014 Dec; 61(6):1312-20. PubMed ID: 25135868 [TBL] [Abstract][Full Text] [Related]
38. Exome analysis of the evolutionary path of hepatocellular adenoma-carcinoma transition, vascular invasion and brain dissemination. Vilarinho S; Erson-Omay EZ; Mitchell-Richards K; Cha C; Nelson-Williams C; Harmancı AS; Yasuno K; Günel M; Taddei TH J Hepatol; 2017 Jul; 67(1):186-191. PubMed ID: 28323122 [TBL] [Abstract][Full Text] [Related]
39. Mutational landscape of a chemically-induced mouse model of liver cancer. Connor F; Rayner TF; Aitken SJ; Feig C; Lukk M; Santoyo-Lopez J; Odom DT J Hepatol; 2018 Oct; 69(4):840-850. PubMed ID: 29958939 [TBL] [Abstract][Full Text] [Related]
40. High-depth sequencing of over 750 genes supports linear progression of primary tumors and metastases in most patients with liver-limited metastatic colorectal cancer. Tan IB; Malik S; Ramnarayanan K; McPherson JR; Ho DL; Suzuki Y; Ng SB; Yan S; Lim KH; Koh D; Hoe CM; Chan CY; Ten R; Goh BK; Chung AY; Tan J; Chan CX; Tay ST; Alexander L; Nagarajan N; Hillmer AM; Tang CL; Chua C; Teh BT; Rozen S; Tan P Genome Biol; 2015 Feb; 16(1):32. PubMed ID: 25808843 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]